Krankenhaus Nordwest | Thoracic Oncology Clinic

Research site

(Unclaimed)

Location

Steinbacher Hohl 2-26, Frankfurt am Main, Hesse, Germany

Site insights

Top conditions

Top treatments

Atezolizumab

Gemcitabine

Bevacizumab

Docetaxel

Osimertinib

Leucovorin

Capecitabine

Cabazitaxel

Romidepsin

5-Fluorouracil

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 15 total trials

A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

A phase 1/2 open-label multicenter study will be performed with an initial dose escalation part to determine the MTD and/or the RP2D of MCLA-129 as m...

Enrolling

Non-Small Cell Lung Cancer Metastatic

Gastric Cancer

Drug: MCLA-129

Drug: Osimertinib

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients (ARASAFE)

The purpose of this clinical phase 3 randomized trial is to compare two different dosing schedules of Docetaxel in combination with ADT and Darolutam...

Enrolling

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Drug: Docetaxel

Drug: Standard ADT (androgen deprivation therapy)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patien...

Enrolling

Metastatic Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Adagrasib

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...

Active, not recruiting

Metastatic Colorectal Cancer

Advanced Colorectal Cancer

Drug: MRTX849

Biological: Cetuximab

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

This is a Phase III, global, multicenter, open-label, randomized study to compare the efficacy and safety of 16 cycles (1 cycle duration=21 days) of...

Active, not recruiting

Non-Small Cell Lung Cancer

Drug: Gemcitabine

Drug: Pemetrexed

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms